Moreover, PLA1A had the highest sensitivity, specificity, and AUC in BRAF-MUT advanced melanoma samples, suggesting that PLA1A could be used as a marker for an effective prediction and diagnosis of advanced BRAF-mutant melanoma cancer. The gene discussed is BRAF; the disease is melanoma.